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Abstract
Nearly 57% of adult Americans report drinking alcohol in the past month, and 41.5% of current
drinkers take alcohol-interactive (AI) medications. Concurrent consumption of both substances
can result in adverse interactions. Nurses are in a position to screen and appropriately teach
patients. However, little is known about nurses’ knowledge of AI medications. The purpose of
this study is to determine nurses’ knowledge of AI medications and factors that may affect
knowledge level. The Jarvis Nursing Knowledge of Alcohol-Interactive Medications survey was
developed and distributed to nurses employed by a large Midwestern health system. The final
analyzed sample of nurses (n = 211) demonstrated lack of AI knowledge by correctly identifying
AI medications only 56.3% of the time. Work environment, years of nursing practice, and
educational level did not have a significant influence in AI knowledge. The authors conclude that
AI medications should be emphasized in nursing curricula so nurses can exercise more vigilance
in nurse-patient interactions.
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Nurses’ Knowledge of Alcohol-Interactive Medications
Alcohol drinking is a popular and profitable leisure time activity in the United States. In
2014, 71.0% of adult Americans ages 18 years and older reported drinking alcohol at some point
in the past year; 56.9% of adult Americans reported drinking least once in the past month,
making them current drinkers; and 24.7% reported binge drinking (consuming five or more
drinks in one sitting) at least once in the past month (Substance Abuse and Mental Health
Services Administration [SAMHSA], 2015). Alcohol consumption is accepted and pervasive in
today’s American culture.
Prescription medication use has been increasingly common in the United States. Kantor,
Rehm, Haas, Chan, and Giovannucci (2015) examined data from the National Health and
Nutrition Examination Survey (NHANES) during the years 1999 to 2012 to identify trends in
prescription medication use. The authors found that 59% of adult Americans used at least one
prescribed medication in the last 30 days in the NHANES 2011-2012 cycle; the stated figure
represented an 8% increase from the NHANES 1999-2000 cycle.
Pharmacologists and prescribers know that both over-the-counter and prescription
medications, such as medications for allergies, angina, depression, and diabetes, have the
potential to interact with alcohol and yield adverse effects (Masters & Trevor, 2015;
Weathermon & Crabb, 1999). Medications that interact with alcohol are referred to as alcohol
interactive (AI) medications. Concurrent consumption of both substances can result in alcoholrelated adverse drug reactions (ADRs), such as sedation, increased risk for bleeding, and
hypotension (Weathermon & Crabb, 1999). Many cases of alcohol-related ADRs result in
emergency department (ED) visits. Holder (1992) estimated that alcohol-drug interactions
contributed to 25% of ED admissions. Castle, Dong, Haughwout, and White (2016) provided a
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more modest estimate of 11.6 ED visits per 100,000 people ages 12 and over were related to
alcohol-drug interactions. The estimate was made by assessing a sample of ED visits from 2005
to 2011, ranging from 229,211-383,977 visits within a given year (Castle, Dong, Haughwout, &
White, 2016).
Alcohol-related ADRs merit the medical attention of healthcare providers. Nurses make
up the largest body of United States healthcare providers, with more than 3.1 million registered
nurses nationwide (Health Resources and Services Administration, 2010). The nation’s nurses
are at the frontline of patient care and are in a position to detect potential alcohol-related ADRs
and provide patient education accordingly (Mitchell et al., 2015). A prerequisite to accurate
health education is knowledge of health content. The aims of this study are to:
1) Assess registered nurses’ level of knowledge of AI medications.
2) Determine whether work environment, years in practice, and level of formal education
contribute to a higher level of AI medication knowledge.
3) Determine to what extent the survey, Jarvis Nursing Knowledge of AI Medications, is
reliable and valid when administered to registered nurses.
Background
Physiology of Alcohol Metabolism and Interactions with Medications
Over 90% of ingested alcohol is metabolized in the liver; the remainder is excreted
through the lungs and in urine (Masters & Trevor, 2015). Acute alcohol consumption has notable
effects on the central nervous system (CNS), heart, and smooth muscle of the body. Alcohol
depresses the CNS by inhibiting the effects of glutamate, the main excitatory neurotransmitter in
the CNS, and enhancing the effects of gamma-aminobutyric acid, GABA, the main inhibitory
neurotransmitter in the CNS. In the heart, alcohol depresses myocardial contractility and slows
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systemic circulation. In smooth muscle, alcohol dilates blood vessels through two mechanisms.
A metabolite in alcohol metabolism, acetaldehyde, directly relaxes smooth muscle. Alcohol also
depresses the vasomotor center of the CNS, also resulting in vasodilation (Masters & Trevor,
2015).
Alcohol-drug interactions are dependent on a number of factors, such as timing of
consumption of the medication(s), timing of consumption of alcohol, dosage of medication, type
of medication, and amount of alcohol. In general, alcohol-drug interactions can be categorized
into two types: pharmacokinetic and pharmacodynamics (Weathermon & Crabb, 1999).
Pharmacokinetic interactions occur when the presence of alcohol interferes with the normal
metabolism of the other medication. The metabolism and excretion of the medication may be
delayed due to the medication having to compete with alcohol for breakdown by the same
enzymatic pathway. Conversely, the metabolism and excretion of the medication may be
accelerated in chronic drinkers whose medication-metabolic pathway was enhanced by chronic
consumption of alcohol; the accelerated metabolism and excretion may result in decreased
therapeutic effects of the active form of the medication. Pharmacodynamic interactions are
independent of enzyme activity and refer to additive effects of alcohol and medications on the
human body (Weathermon & Crabb, 1999). For instance, concurrently ingesting a medication
with CNS depressant qualities and alcohol will yield a greater degree of CNS depression than if
the two substances were consumed independently.
Prevalence of Alcohol-Medication Interactions
Much of the literature addressing the prevalence of AI medications focuses on the more
vulnerable population of older adults (Adams, 1995; Cousins et al., 2014; Forster, Pollow, &
Stoller, 1993; Immonen, Valvanne, & Pitkala, 2013; Pringle, Ahern, Heller, Gold, & Brown,
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2005; Qato, Manzoor, & Lee, 2015). The vulnerability is a result of the higher likelihood that
older adults engage in polypharmacy and are more sensitive to the effects of alcohol (Moore,
Whiteman, & Ward, 2007). The earliest reported studies were performed in the 1990s. Forster,
Pollow, and Stoller (1993) found that 25% of community-based older adults were at risk for at
least one alcohol-related ADR, while 15% were at risk for multiple alcohol-related ADRs. The
most common risk was that of over-the-counter pain medications and alcohol, as both substances
delay clotting time and increase the risk of bleeding. Adams (1995) estimated 38% of older
adults concurrently consumed alcohol and AI medications, the most common being
cardiovascular agents such as antihypertensive medications.
More recent studies, international and domestic, have proposed different estimates.
Pringle, Ahern, Heller, Gold, and Brown (2005) used data from a state-based medication
assistance program for older adults and found that 77% of program participants were exposed to
AI medications; concurrent alcohol use was found in 19% of program participants. Qato,
Manzoor, and Lee (2015) used data from the National, Social life, Health and Aging Project to
characterize the extent of drug-alcohol interactions in older adults. The authors found that 20%
of older adults were at-risk for a drug-alcohol interaction. This estimate is more striking due to
the authors defining regular drinking as consuming alcohol at least weekly, rather than the
SAMHSA definition of one drink per month for current drinking.
The high risk for alcohol-medication interactions in older adults is found internationally.
Immonen, Valvanne, and Pitkala (2013) assessed the possibility of drug-alcohol interactions
among older adults in Finland. The authors determined that 34.9% of current drinkers (one drink
per month) were on AI medications. In Ireland, Cousins et al. (2014) used a sample of adults
ages 60 years and older to estimate the prevalence of AI medications and concurrent alcohol
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consumption. The authors found that 60% of older adults concurrently used AI medications and
alcohol.
Two United States studies used data from the NHANES, a research survey program
conducted by the National Center for Health Statistics. Jalbert, Quilliam, and Lopane (2008)
used NHANES 1999-2002 data and found that 13.5% of participants ages 20 and over took one
or more AI medications; 60.5% of those participants reported concurrent drinking. To determine
the national prevalence of AI prescription medication use among current drinkers ages 65 years
and older, Breslow, Dong, and White (2015) used the same methodology as Jalbert, Quilliam,
and Lopane (2008) but extended the data collection interval to 1999-2010. The authors found
that 41.5% of current drinkers were on AI medications. Thus, these studies show that AI
medications are abundantly available to the United States population. However, with the
exception of Jalbert, Quilliam, and Lopane (2008), the literature is limited by its focus on the risk
of alcohol-medication interactions in older adults rather than people of all ages.
Nursing Education and Knowledge on Substance Misuse
The American Association of Colleges of Nursing’s (AACN, 2008) The Essentials of
Baccalaureate Education for Professional Nursing Practice delineates core standards that
baccalaureate-degree nursing programs must meet when developing curricula. Essential VII:
Clinical Prevention and Population Health defines health promotion and disease prevention as
essential skills a baccalaureate nurse should have. Competency in identifying risky concurrent
use of alcohol and AI medications is consistent with Essential VII. However, the literature shows
a deficit in alcohol-drug related knowledge of graduate nurses and content in nursing curricula
over the last three decades, with a minority of studies addressing drug misuse at all (Happell &
Taylor, 1999; Hoffman & Heinemann, 1987; Howard, Walker, Walker, & Suchinsky, 1997;
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Mollica, Hyman, & Mann, 2011; Murray & Li, 2007; Murray & Savage, 2010; Vadlamudi,
Adams, Hogan, Wu, & Wahid, 2008;). Vadlamudi, Adams, Hogan, Wu, and Wahid (2008)
claimed that healthcare educators are faced with time constraints that do not allow for focused
content on alcohol when they are trying to establish a broad foundation of healthcare knowledge.
The deficit of alcohol misuse content in nursing curricula results in nurses unable to properly
identify, refer, and educate patients who misuse alcohol (Adams, Hogan, Wu, & Wahid, 2008;
Rassool & Rawaf, 2008a; Rassool & Rawaf, 2008b; Vadlamudi, Tsai et al., 2010). Alcohol
misuse in the literature is typically defined as the consumption of psychoactive substances in
ways they were not intended and that causes physical, social and psychological harms (Rassool,
2004). Alcohol abuse, addiction, and dependence are salient issues when referring to alcohol
misuse, but alcohol-medication interactions are also considered in alcohol misuse.
Nurses represent the largest group of healthcare professionals who are often the initial
assessors for high-risk alcohol use (Rassool, 1993). However, nursing schools only allot a few
hours of alcohol-related content, focusing mainly on abuse, addiction, and dependence. Hoffman
and Heinemann (1987), the oldest study concerning alcohol education in nursing curricula,
surveyed 242 nursing programs in the United States to find how much substance abuse education
is provided to nursing students. The most frequently reported range of hours is one to five; 87%
of surveyed schools reported offering alcoholism content, while only 35% of surveyed schools
reported offering drug abuse content. Mollica, Hyman, and Mann (2011) evaluated if alcohol
education in undergraduate nursing curricula had changed since the findings of Hoffman and
Heinemann (1987). The authors performed a cross-sectional survey of 117 traditional 4-year
baccalaureate nursing programs in Northeastern United States. They found that 56% of schools
offered one to five hours of didactic alcohol education, and 30% of schools offered one to five
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clinical hours of alcohol education. Current findings show little change in alcohol education in
United States baccalaureate nursing programs in two decades. A similar paucity of alcohol
education is found in the United Kingdom. There, inclusive range of time allotted for didactic
and clinical alcohol education in undergraduate nursing programs are two to 10 hours (Cund,
2013; Holloway & Webster, 2013; Howard, Walker, Walker, & Suchinsky, 1997). Specialist
drug and alcohol nurses have reported poor preparation, as well as a lack of opportunities for
alcohol- and drug-related continuing education in their own specialty (Happell & Taylor, 1999).
Nurse practitioners have reported the same lack of alcohol-drug content in graduate school
(Campbell-Heider et al., 2009). Overall, the education of alcohol misuse is lacking in nursing
education.
Though nursing schools have not significantly integrated more drug- and alcohol-related
content in their curricula, there have been a couple of notable attempts. Rassool (2004) described
the development of a substance misuse curriculum for non-addictions specialist nurses. British
nurses from any field could take advantage of the continuing education and earn a Certificate in
Substance Misuse in England (Rassool, 2004). In the United States, an online curriculum was
developed by the National Institute on Alcohol Abuse and Alcoholism (NIAAA) (Murray &
Savage, 2010). The online curriculum available on the NIAAA website includes PowerPoint
lectures, handouts, resources, modules, and suggested classroom activities that span fourteen
alcohol-related topics (e.g., alcohol’s effect on the brain and behavior, prevention of harm from
alcohol use) (Murray & Savage, 2010).
There is a dearth of evidence in the literature of the degree to which AI medications are
covered as sufficiently as alcohol abuse, addiction, and dependence when addressing alcohol
misuse. Neafsey and Shellman (2002) is the only study found that quantified the level of
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knowledge nurses have about interactions of medications and alcohol. The authors distributed a
multiple-choice survey of 14 interactions among over-the-counter medications, prescription
medications, and alcohol to three groups of nurses: visiting nurse agency registered nurses
(VNARNs) (n=20), undergraduate nursing students (n=20), and graduate nursing students
(n=31). Medications the survey covered include non-steroidal anti-inflammatory drugs (e.g.,
aspirin), acetaminophen, antacids, antihypertensives, warfarin, and zinc. Surveyed nurses were
only capable of correctly identifying 49-59% of medication-alcohol interactions. The authors
found VNARNs had significantly greater knowledge than the graduate nursing students, though
the study’s major shortcoming is small sample sizes.
Methods
Sample
A convenience sample of 931 registered professional nurses employed by a large
Midwestern health system was used in this study. The health system consists of two inpatient
locations and 20 outpatient clinics in Illinois. The health system has Magnet accreditation, a
credential awarded by the American Nurses Credentialing Center to reflect nursing excellence.
Eligibility requirements for participants in this study included being 18 years of age or older,
English literacy, and being a registered professional nurse employed by the health system.
Data collection occurred over four weeks. Of the potential 931 registered professional
nurses, 503 participants completed the electronically distributed survey, resulting in a 54%
response rate. Completion of the survey was considered consent (Appendix A). Exclusion
criteria include partial completion, duration of survey completion under five minutes, and at least
three medication questions skipped. The final sample size for data analysis was 211.
Instrument
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Knowledge of AI medications was measured by using the Jarvis Nursing Knowledge of
AI Medications (JaNKAM) Survey, which was developed in 2016 (Appendix B). The survey
includes questions pertaining to 15 of 25 most commonly prescribed medications in the United
States, using data from the Centers for Medicare and Medicaid Services, the Institute for
Healthcare Informatics, and the Centers for Disease Control and Prevention. Of the 15
medications, 10 are AI. The survey asks the participant: 1) if patient teaching on AI medications
is part of a typical patient interaction; 2) which resource the participant would most likely use to
learn more about AI medications; 3) a series of questions regarding specific AI medications; and
4) of any additional comments she or he would like to make. Each set of questions pertaining to
a medication has a primary question and a secondary question. The primary question asks
whether or not the medication is AI. If the respondent answers no, the survey continues to the
next set of questions about another medication. If the respondent answers yes, the survey
transitions to the secondary question that asks what alcohol related ADR might occur. Each
secondary question has one correct answer and three distractors. The survey includes both the
generic and the brand names of each drug.
Data Analysis
Data analysis was conducted by using IBM SPSS Statistics (version 22). Descriptive
statistics and frequencies were used to describe demographic characteristics and to score the
accuracy of participants’ answers to the JaNKAM survey. Because data were not normally
distributed, nonparametric tests were used to answer Aim 2. Specifically, the Mann-Whitney U
test and the chi-square test were utilized. The Mann-Whitney U test is a nonparametric test that
determines if the difference between two means is statistically significant; it is the nonparametric
equivalent of the t-test (Field, 2009). The chi-square test determines if there is a relationship
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between two or more categorical variables (Field, 2009). The observed frequencies were
classified simultaneously for years in nursing practice. The join frequencies were tested against
the null hypothesis (e.g., there is no differences within nurses’ knowledge of AI medications and
the number of years they have practiced in nursing).
Due to a large sample size, however, parametric tests were also utilized for further
investigation of statistical significance. Specifically, t-tests and 1-way Analysis of Variance
(ANOVA) were utilized. A 1-way ANOVA was conducted to compare mean scores between
three or more groups of nurses. The level of statistical significance for this study was α = 0.05.
No a priori power analysis was conducted, as no known population μ was available to
compare finding against. Only one clinical site was used for this pilot study. However, due to the
robust response rate, post hoc power analysis was conducted. A small effect size was chosen, as
the authors reasoned that the sample of nurses would not differ when compared to the population
of United State nurses. The effect size is an objective and often standardized measure of the
magnitude of an observed effect (Field, 2009). With a small effect size (0.20), α = 0.05, df = 1, n
= 211, Cohen (1988) determined that the power for the chi-square test is 81%. For a df = 2,
power was determined to be 72%.
Results
Demographics
The majority of participants in the sample were female (n = 200, 94.8%). All age groups
were represented with the highest number in ages 50-59 (n = 55, 26.1%), followed by the ages
30-39 (n = 50, 23.7%). Most of the participants identified themselves as Caucasian (n = 192,
91.0%), followed by “Other” (n = 7, 3.3%). The nurses surveyed were fairly evenly distributed
between working in the hospital (n = 108, 51.2%) and working in an outpatient setting (n = 101,
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47.9%). The highest degree held by 96 (45.5%) of participants was an Associate Degree in
Nursing (ADN), followed by 91 (43.1%) participants with a Baccalaureate in Nursing (BSN).
Regarding years worked in nursing practice, the majority of nurses worked 21 years or more (n =
77, 36.5%), followed by nurses who worked 1-5 years (n = 50, 23.7%), and nurses who worked
6-10 years (n = 35, 16.6%). A demographic breakdown is found in Tables 1 and 2 (Appendix C).
Registered Nurses’ Level of Knowledge of AI Medications
The first aim of the study is to determine nurses’ knowledge of AI medications. The
measure of knowledge is based on the number of answers correctly identified. A JaNKAM score
is defined as a percent of correct responses. The median JaNKAM score was 60%, and the mean
score was 56.3%, SD = 19.90%, ranged from 0% to 93.3%. Nurses only correctly identified
about 56-60% of medications as AI or non-AI. The participants (n=2) with a score of 0% did not
meet any exclusion criteria and were therefore kept. The most correctly classified medication is
hydrocodone-acetaminophen (Vicodin); 98.6% of the sample identified the medication is AI.
The least correctly classified medications were ciprofloxacin (Cipro) and prednisone (22.7%).
Both medications are not AI.
Also, the AI medications were exclusively score. Rather than measuring AI medication
knowledge by a participant’s ability to correctly discriminate medications as AI or non-AI, the
authors also observed how well participants detect AI medications from a list of exclusively AI
medications. The median score was 80%, and the range was 0% to 100%; the mean score was
70.2%, SD = 27.92. Nurses were capable of correctly identifying 70% of AI medications from a
list of AI medications. Score breakdowns for all medications and exclusively AI medications are
found in Tables 3-6 (Appendix D).
Comparison of JaNKAM Scores
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The second aim of this study is to determine whether work environment, years in
practice, and level of formal education contribute to a higher level of AI medication knowledge.
Work environment. The scores of nurses who worked at the hospital and nurses who
worked at outpatient clinics were compared. AI medication knowledge in hospital nurses (Mdn =
60.0%; M = 55.42%) did not differ significantly from clinic nurses (Mdn = 60.0%; M = 57.10%),
U = 5072, z = -0.882, ns, r = -0.06. These results suggest that nurses in both work environments
have approximately equal levels of knowledge of AI medications. The t-test results reinforced
the lack of statistical significance. Scores by groups are found in Table 7 (Appendix E).
Level of formal education. The scores of nurses with an Associates Degree in Nursing
(ADN) and nurses with a Bachelor of Science in Nursing (BSN) were compared; an ADN is
typically obtained in two-year programs, and a BSN is typically obtained in four-year programs.
AI medication knowledge in ADN nurses (Mdn = 60%; M = 56.25%) did not differ significantly
from BSN nurses (Mdn = 60%; M = 56.41%), U = 4284.5, z = -0.228, ns, r = -0.017. These
results suggest that ADN and BSN nurses have approximately equal levels of AI medication
knowledge. The t-test results reinforced the lack of statistical significance. Scores by groups are
found in Table 7 (Appendix E).
Years of nursing practice. The scores of nurses grouped into three ranges of nursing
practice were compared. The group ranges for years in nursing practice are of the following: 0-5
years, 6-20 years, and 21 or more years. There was no significant association between years in
nursing practice and accurate discrimination of medications as AI or non-AI χ2 (28) = 27.54, p =
0.48, Cramer’s V = 0.225. Cramer’s V is an effect size commonly associated with the chi-square
test; the stated value signifies a small effect size but is not statistically significant. These results
suggest that years in nursing practice do not affect levels of AI medication knowledge. The
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ANOVA results reinforced the lack of statistical significance. Further, post-hoc analysis was
conducted. One cell of the crosstabulation, 21 years and over crossed with 12 correct answers,
had an adjusted residual greater than 1.96. However, the analysis still indicated no statistical
significance.
Reliability and Validity of the JaNKAM
The third aim of the study is to determine the reliability and validity of the JaNKAM
survey. The face validity of the JaNKAM survey was established prior to distribution by three
alcohol researchers. One researcher approved the survey with no suggestions for changes. The
two other researchers gave feedback that was adopted for the final survey draft.
To determine the reliability of the JaNKAM, internal consistency was measured using the
alpha coefficient Kuder-Richardson 20 (KR-20). Internal consistency is the degree to which all
items on a scale measure the same trait (Polit & Beck, 2010). The KR-20 is a reliability index
that is used for nominal data that are scored dichotomously (Waltz, Stickland, & Lenz, 2010).
The KR-20 is appropriate for the JaNKAM because the survey was scored for accuracy, or in a
correct/incorrect dichotomy.
The KR-20 values for primary and secondary questions, both individually and together,
were ascertained. The KR-20 value for primary questions was reliable (α = 0.714). The KR-20
values for exclusively secondary questions (α = 0.510) and inclusively primary and secondary
questions (α = 0.628) demonstrated lower levels of reliability. Due to the lower degree of
reliability of the entire JaNKAM, validity of the JaNKAM should be interpreted with caution.
Discussion
This cross-sectional study examined nurses’ knowledge of AI medications, as well as
whether or not relationships exist between level of AI medication knowledge and level of
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education, work environment, and years of nursing practice. The findings demonstrated no
significant relationship between level of AI medication knowledge and level of education, work
environment and years of nursing. Considering only the 10 of the 15 medications that are
actually AI, nurses identified them as such 70% of the time. However, nurses overall were only
capable of correctly discriminating 56.3% of the 15 most prescribed medications as AI or nonAI. BSN nurses scored slightly higher than ADN nurses, though the difference in scores was not
significant. Nurses with more years of clinical experience scored higher than nurses with less
clinical experience, though the difference in scores was not significant. Outpatient clinic nurses
scored slightly higher than hospital nurses, though the difference in scores was not significant.
Nurses, regardless of years of accumulated practice, work setting, and level of formal education,
are not familiar with AI medications.
To the researchers’ knowledge, only one previous study (Neafsey & Shellman, 2002) had
attempted to measure nurses’ level of AI medication knowledge. Neafsey and Shellman (2002)
examined level of AI medication knowledge only in a small sample size of community health
nurses. The authors primarily focused on over-the-counter medications, while our study
thoroughly addressed 15 of the most commonly prescribed medications in the United States.
Thus, our study is the first to investigate nurses’ knowledge of AI medications among a large
number of nurses in all practice settings.
These findings reinforce what is known in the literature about nursing curricula and the
low level of preparation for new nurses to engage patients who misuse alcohol. Overall, nursing
curricula is deficient in proper alcohol misuse education. Further, little alcohol misuse content in
curricula typically address alcohol abuse, addiction, and dependence. The amount of didactic
instruction about AI medications is unknown. The mean score of all sampled nurses indicates
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that nurses must be better trained at differentiating between AI medications and non-AI
medications.
Limitations
The convenience sample (n=211), harvested from 503 respondents, was taken from a
single site, a large Midwestern health system. Further, the health system holds a Magnet
accreditation, reflecting a high standard of nursing excellence. Both a single-site convenience
sample at a hospital system with a higher standard of nursing excellence limits generalizability of
results to the entire population of United States nurses (Polit & Beck, 2013). The participants
were not observed when they completed the JaNKAM, as the survey was distributed
electronically. A variety of environmental factors may have prevented nurses from focusing and
answering survey items to the best of their abilities. Moreover, unobserved completion of the
survey includes the risk of participants searching up correct answers in references such as drug
books or the Internet.
The JaNKAM survey was developed for this study, and study limitations come from this
pilot survey. The survey was written in a way that collected data nominally; therefore, nominal
data limited the options of analysis. There is some flux between nominal and ordinal data in the
current study. For the purposes of this study, data for Aims 1 and 2 was categorical and analyzed
with the nonparametric statistics. However, the pilot survey will be improved so that its results
will afford a more robust statistical analysis in future studies.
Moreover, the authors found that the average amount of time completing the JaNKAM
was 22 minutes. Response burden and survey fatigue may have resulted in participants not
answering items to the best of their abilities. Further, an error in distribution occurred. The
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secondary question for metoprolol (Lopressor) was invalid due to a technical error in which a
multiple-choice answer was stated as the question.
Responses to the JaNKAM survey may have also been influenced by an acquiescence
bias. An acquiescence bias is the tendency in which a respondent agrees to survey questions
(Polit & Beck, 2013). The JaNKAM was introduced to respondents as a test for AI medications,
which may have primed respondents to answer affirmatively to the primary questions. Evidence
supporting the presence of this bias is how participants scored better if the 10 AI medications
were exclusively observed rather than the total 15 medications.
Therefore, the survey will be modified for future studies. The next iteration of the survey
will have one question per medication. Each medication question will have five multiple-choice
answers; the question will ask how the medication interacts with alcohol. The first four multiplechoice answers will be a mechanism-based answer, and the fifth answer will be a statement that
the medication does not interact with alcohol. The reduction in the number of questions will ease
survey fatigue and response burden, while still sustaining the questions’ capabilities of
measuring AI medication knowledge. Further, the survey will be redesigned to collect data at
levels higher than nominal. For the current study, years of nursing practice and age were
collected in nominal intervals. Future modification of the survey will allow respondents to input
a precise value. To address acquiescence bias, the next iteration of the survey will include an
equal number of AI and non-AI medications, and the questions will be phrased neutrally in ifhow form.
The 10 AI medications on the JaNKAM survey are pharmacologically interactive with
alcohol, but the clinical significance of the alcohol-medication interaction was not assessed.
Before the next iteration of the JaNKAM, an investigator will consult an additional expert (e.g., a
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medical doctor with a PhD in clinical pharmacology) to discuss each AI medication. The authors
of the current study also did not define how many alcohol drinks a patient would need would
need to consume daily for alcohol-medication interactions to be clinically significant.
Though the primary questions of the survey were sufficiently reliable (KR-20 value of
0.71), both the secondary questions and the combined primary and secondary questions resulted
in insufficient reliability. The reliability of the secondary questions are made further complicated
because the appearance of the secondary question is dependent how the participant will respond
to the primary question. Moreover, only face validity of the survey was appraised for the current
study. Future iterations of the survey should utilize content validity indices to appraise the
validity of the JaNKAM survey prior to distribution.
Future Research
The JaNKAM was developed for the purposes of this study. After modification of the
survey that addresses its limitations, the survey may be used in future studies and be assessed for
changes in reliability and validity. The generalizability of current results should also be
reevaluated. Further, although the deficit of alcohol-related material in nursing curricula is well
documented in the literature, most studies focused on alcohol abuse, addiction, and dependence.
Future studies should aim to precisely measure how much nursing schools cover AI medications
with students. Future studies may also investigate how much clinical time is spent by healthcare
providers in educating patients about the risks of concurrent consumption of alcohol and
medications.
Conclusion
Although 41.5% of current drinkers are prescribed at least one AI medication (Breslow,
Dong, & White, 2015), we found that the sampled nurses were not capable of differentiating
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between AI and non-AI medications from a list of 15 commonly prescribed medications. A key
role of nurses is to be vigilant of health risks, such as alcohol-related ADRs, and provide health
education accordingly, as defined by The Essentials of Baccalaureate Education for Professional
Nursing Practice (AACN, 2008). Based on this pilot study, nurses should be given continuing
education opportunities to review AI medication content and equip themselves with the essential
skills to prevent alcohol-related ADRs.
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Appendix A
Email Invitation Asking Participants to Complete Survey & Consent

Jarvis Survey on Alcohol Interactive Medications
You are invited to participate in a research study on awareness of prescription medications and
alcohol drinking. Your responses are important in helping us plan continuing education for
nurses. This study is conducted by Carolyn Jarvis and Kyle Serafico from Illinois Wesleyan
University.
This study will take about 15 minutes of your time. You will be asked to answer a few basic
demographic questions, and questions about specific commonly prescribed medications and their
interaction with alcohol.
Your decision to participate in this study is completely voluntary. You have the right to stop your
participation at any time without penalty. You may skip any questions you do not want to
answer. If you do not want to complete this survey just close your browser.
Your participation in this research will be completely confidential and data will be averaged and
reported in aggregate. Possible outlets of these data may be conferences and publication in peerreviewed journals. Although your participation in this research may not benefit you personally, it
will help us very much in planning nursing continuing education regarding alcohol-interactive
medications and patient safety.
The primary risk in this study is loss of confidentiality. But, because the survey is being
completed online and no identifiable data are being collected, the risk to loss of confidentiality is
minimal. All information will remain confidential.
If you have questions about this project, you may contact Carolyn Jarvis, PhD, APRN (309-5563297; cjarvis@iwu.edu). If you have any questions about your rights as a participant in this study
or any concerns or complaints, please contact the Illinois Wesleyan University IRB at 309-5563255 or via email at irb@iwu.edu.
Please print a copy of this consent form for your records, if you wish.
Your decision to participate, decline, or withdraw from participation will have no effect on your
current status or future relations with Carle Foundation Hospital or Illinois Wesleyan University.
By completing this survey, you are consenting to participate in this study.
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Survey Tool: Jarvis Nursing Knowledge of AI Medications (JaNKAM) Survey

Q1 What gender?
 Female
 Male
 Transgender
Q2 Age in years
 18-29 years
 30-39 years
 40-49 years
 50-59 years
 60 years and above (5)
Q3 How many years have you worked in nursing practice?
 0-1
 1-5
 6-10
 11-15
 16-20
 21 years or more
Q4 What is your current role/profession?
 Registered Nurse/Staff Nurse
 Advanced practice nurse
 Nurse educator
 Nurse administrator
Q5 Where in the hospital system do you work?
 Hospital
 Outpatient Clinics
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Q6 If you answered "Hospital," which unit?
 Medical/surgical
 Step Down
 Obstetrics
 Pediatrics
 NICU
 CCU/ICU
 OR/PACU
 Special procedures
 Other ____________________
Q7 If you answered "Outpatient Clinics," which Clinic?
 Family practice
 Internal medicine
 Pediatrics
 Other ____________________
Q8 With what ethnic origin do you affiliate?
 African American
 Asian
 Caucasian
 Latino/a
 Other ____________________
Q9 Highest degree held
 Associate degree in Nursing (ADN)
 Baccalaureate in Nursing (BSN)
 Masters in Nursing (MSN)
 Masters in other field
 Doctorate Nursing Practice (DNP)
 PhD in Nursing
 PhD in other field
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Q10 Is patient teaching on alcohol interactive (AI) medications part of your daily routine on all
patients?
 Yes
 No
Display This Question:
If Is patient teaching on alcohol interactive (AI) medications part of your daily routine on all
patients? Yes Is Selected
Q11 How much time do you spend on teaching alcohol-interactive medications?
 A great deal
 A lot
 A moderate amount
 A little
Q12 If a patient is diagnosed with alcohol use disorder, is patient teaching on alcohol interactive
medications part of your daily routine?
 Yes
 No
Display This Question:
If If patient is diagnosed with alcohol disorder, is patient teaching on AI medications part of
you... Yes Is Selected
Q13 How much time do you spend on teaching AI medications?
 A great deal
 A lot
 A moderate amount
 A little
Q14 What source would you use to learn about alcohol interactive medications? (Check all that
apply)
 Application on mobile phone
 Web-based program
 Pharmacology book
 Physician or Nurse Practitioner Prescriber
 Call the pharmacy
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Q15 Each question below will identify a common medication given in the hospital or outpatient
setting. Assume the patient drinks 1-2 standard alcohol drinks per day. Please look at each
medication and answer whether it is alcohol-interactive. If the medication interacts with alcohol,
then answer the following question on the way it interacts. Please do not use any device or book
references as you answer these questions. We just want to learn a baseline for nursing education.
It is OK if you do not know an answer.
Q16 When taken together, do Hydrocodone/Acetaminophen (Lortab, Vicodin, Norco) and
alcohol interact?
 Yes
 No
 I have no experience with this medication
Display This Question:
If When taken together, do Hydrocodone/Acetaminophen (Lortab, Vicodin, Norco) and
alcohol interact? Yes Is Selected
Q17 How do hydrocodone/acetaminophen and alcohol interact?
 Both substances cause respiratory depression and sleepiness
 Both substances cause high blood pressure crisis
 Both substances cause kidney toxicity
 Alcohol decreases pain relief of hydrocodone/acetaminophen
Q18 When taken together, do simvastatin (Zocor) and alcohol interact?
 Yes
 No
 I have no experience with this medication
 Click to write Choice 4
Display This Question:
If When taken together, do simvastatin (Zocor) and alcohol interact? Yes Is Selected
Q19 How do simvastatin (Zocor) and alcohol interact?
 Both substances increase risk of heart attack
 Both substances increase risk of diabetes
 Alcohol causes high blood cholesterol and cancels statin benefits
 Both substances increase risk of myopathy
Q20 When taken together, do hydrochlorothiazide (Hydrocot) and alcohol interact?
 Yes
 No
 I have no experience with this medication
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Display This Question:
If When taken together, do hydrochlorothiazide (Hydrocot) and alcohol interact? Yes Is
Selected
Q21 How do hydrochlorothiazide and alcohol interact?
 Both substances increase risk of peripheral edema
 Both substances increase risk of hearing loss
 Both substances increase risk of enlarged breasts in men and menstrual irregularities in
women
 Both substances decrease blood pressure
Q22 When taken together, do omeprazole (Prilosec) and alcohol interact?
 Yes
 No
 I have no experience with this medication
Display This Question:
If When taken together, do omeprazole (Prilosec) and alcohol interact? Yes Is Selected
Q23 How do omeprazole and alcohol interact?
 Both substances increase risk of pneumonia
 Both substances increase risk of osteoporosis and fractures
 both substances increase risk of intestinal infection with Clostridium difficile
 Alcohol increases risk of acid rebound when stopping omeprazole
Q24 When taken together, do ibuprophen (Advil) and alcohol interact?
 Yes
 No
 I have no experience with this medication
Display This Question:
If When taken together, do ibuprophen and alcohol interact? Yes Is Selected
Q25 How do ibuprophen and alcohol interact?
 Both substances Increase risk of edema
 Both substances Increase risk for bleeding
 Both substances Increase risk of kidney toxicity
 Both substances increase risk of high blood potassium
Q26 When taken together, do levothyroxine (Levoxyl, Synthyroid) and alcohol interact?
 Yes
 No
 I have no experience with this medication
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Display This Question:
If When taken together, do levothyroxine (Levoxyl, Synthyroid) interact? Yes Is Selected
Q27 How do levothyroxine and alcohol interact?
 Alcohol reduces levothyroxine absorption
 Alcohol increases levothyroxine metabolism
 Both substances increase risk of myxedema coma
 Both substances increase risk of simple goiter
Q28 When taken together, do lisinopril (Zestril, Prinivil) and alcohol interact?
 Yes
 No
 I have no experience with this medication
Display This Question:
If When taken together, do lisinopril (Zestril, Prinivil) interact? Yes Is Selected
Q29 How do lisinopril and alcohol interact?
 Both substances increase risk of edema of tongue, lips or eyelids
 Both substances decrease blood pressure
 Both substances increase risk of cough
 Both substances increase risk of high blood potassium
Q30 When taken together, do amlodipine (Norvasc) and alcohol interact?
 Yes
 No
 I have no experience with this medication
Display This Question:
If When taken together, do amlodipine (Norvasc) interact? Yes Is Selected
Q31 How do amlodipine and alcohol interact?
 Both substances increase risk of headache
 Both substances increases risk of peripheral edema
 Both substances increase risk of constipation
 Both substances decreased blood pressure
Q32 When taken together, do furosemide (Lasix) and alcohol interact?
 Yes
 No
 I have no experience with this medication
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Display This Question:
If When taken together, do furosemide (Lasix) and alcohol interact? Yes Is Selected
Q33 How do furosemide and alcohol interact?
 Both substances decrease blood pressure
 Both substances increase risk of potassium loss
 Both substances increase risk of hearing loss
 Alcohol stops the diuretic effect of furosemide
Q34 When taken together, do ciprofloxacin (Cipro) and alcohol interact?
 Yes
 No
 I have no experience with this medication
Display This Question:
If When taken together, do ciprofloxacin (Cipro) and alcohol interact? Yes Is Selected
Q35 How do ciprofloxacin and alcohol ineract?
 Both substances increase risk of tendon injury
 Both substances cause nausea and vomiting
 Both substances increase risk of Candida infections
 Both substances increase risk of severe sunburn
Q36 When taken together, do prednisone and alcohol interact?
 Yes
 No
 I have no experience with this medication
Display This Question:
If When taken together, do prednisone and alcohol interact? Yes Is Selected
Q37 How do prednisone and alcohol interact?
 Both substances suppress the adrenal glands
 Both substances increase risk of fungal infection
 Both substances increase physiologic stress
 Alcohol speeds up glucocorticoid withdrawal
Q38 When taken together, do metformin (Glucophage) and alcohol interact?
 Yes
 No
 I have no experience with this medication
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Display This Question:
If When taken together, do metformin (Glucophage) and alcohol interact? Yes Is Selected
Q39 How do metformin and alcohol interact?
 Both substances decrease appetite and cause nausea and vomiting
 Both substances cause weight gain
 Both substances allow buildup of lactic acid in the blood
 Both substances increase risk of acute kidney failure
Q40 When taken together, do gabapentin (Neurontin) and alcohol interact?
 Yes
 No
 I have no experience with this medication
Display This Question:
If When taken together, do gabapentin (Neurontin) and alcohol interact? Yes Is Selected
Q41 How do gabapentin and alcohol interact?
 Both substances cause dizziness and sleepiness
 Both substances increase risk for headache
 Both substances increase risk for peripheral edema
 Both substances cause blurred vision
Q42 When taken together, do metoprolol (Lopressor) and alcohol interact?
 Yes
 No
 I have no experience with this medication
Display This Question:
If When taken together, do metoprolol (Lopressor) and alcohol interact? Yes Is Selected
Q43 Both substances increase risk of migraine headaches
 Both substances increase risk of hyperthyroidism
 Both substances cause constriction of breathing tubes
 Both substances decrease blood pressure
Q44 When taken together, do losartan (Cozaar) and alcohol interact?
 Yes
 No
 I have no experience with this medication
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Display This Question:
If When taken together, do losartan (Cozaar) and alcohol interact? Yes Is Selected
Q45 How do losartan and alcohol interact?
 Both substances cause swelling of the lips, tongue or eyelids
 Both substances decrease blood pressure
 Both substances cause kidney failure
 Both substances increase levels of potassium in the blood
Q46 Any additional comments?
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Appendix C

Table 1: Demographic Characteristics of Participants (Sex, Age, Ethnicity, Work Setting)

Variable

Actual Number

% of total sample

Female

200

94.8

Male

11

5.2

18-29 years

41

19.4

30-39 years

50

23.7

49-49 years

40

19.0

50-59 years

55

26.1

60 years and above

25

11.8

African American

5

2.4

Asian

6

2.8

Caucasian

192

91.0

Latino/a

1

.5

Other

7

3.3

Inpatient Hospitals

108

51.2

Outpatient Clinics

101

47.9

Sex

Age

Ethnicity

Work Setting
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Table 2: Demographic Characteristics of Participants (Formal Education, Years in Nursing)

Variable

Actual Number

% of total sample

Associate Degree in Nursing (ADN)

96

45.5

Bachelor’s of Science in Nursing (BSN)

91

43.1

Master’s of Science in Nursing (MSN)

16

7.6

Master’s in other field

4

1.9

0-1 years

3

1.4

1-5 years

50

23.7

6-10 years

35

16.6

11-15 years

21

10.0

16-20 years

25

11.8

21 years or more

77

36.5

Level of Formal Education

Years in Nursing Practice
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Appendix D
Table 3: Overall Score Breakdown of the JaNKAM

Percent Correct
N

Valid
Missing

Mean
Median
Std. Deviation
Variance
Range
Minimum
Maximum

211
0
56.2717
60.0000
19.9045
8
396.192
93.33
.00
93.33

Table 4: Breakdown of JaNKAM Scores by Medication: Primary Questions

Medication
HydrocodoneAcetaminophen
Simvastatin
Hydrochlorothiazide
Omeprazole
Ibuprofen
Losartan
Metoprolol
Gabapentin
Ciproflaxacin
Metformin
Levothyroxine
Prednisone
Lisinopril
Furosemine
Amlodipine

Frequency of Correct Response to
Primary Question (n = 211)
208

Proportion

51
136
75
152
115
147
136
48
159
77
48
139
159
131

24.20%
64.50%
35.50%
72.00%
54.50%
69.70%
64.50%
22.70%
75.40%
36.50%
22.70%
65.90%
75.40%
62.10%

98.60%
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Table 5: Breakdown of JaNKAM Scores by Medication: Secondary Questions
Medication

Frequency of
Correct Response to
Secondary Question
187

Number of "Yes"
Responses to
Primary Question
208

Proportion

Hydrocodone89.90%
Acetaminophen
Simvastatin
X
X
X
Hydrochlorothiaz 122
136
89.70%
ide
Omeprazole
X
X
X
Ibuprofen
115
152
75.70%
Losartan
83
115
72.20%
Metoprolol
Error
Error
Error
Gabapentin
123
136
90.40%
Ciproflaxacin
X
X
X
Metformin
59
159
37.10%
Levothyroxine
X
X
X
Prednisone
X
X
X
Lisinopril
108
139
77.70%
Furosemine
62
159
39%
Amlodipine
110
121
90.90%
X – The secondary question has no correct answer, as the medication is not alcohol-interactive
Table 6: Breakdown of JaNKAM Scores of Exclusively AI Medications

% Scores of Exclusively AI Medications
N

Valid
Missing

Mean
Median
Std. Deviation
Variance
Range
Minimum
Maximum

211
0

70.2
80.0
27.92
1
10
00
10
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Appendix E

Table 7: Statistics by Work Setting and Formal Education
Work Setting

N

Mean

Median

Std.
Deviation

Std. Error
Mean

Hospital

108

55.6173

60.0000

18.68273

1.79775

Outpatient Clinics
Formal Education
Associate degree in Nursing
(ADN)
Baccalaureate in Nursing
(BSN)

101

57.0957

60.0000

20.94258

2.08387

96

56.2500

60.0000

21.66869

2.21155

91

56.4103

60.0000

19.20154

2.01287

